Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "safety"

1850 News Found

AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy
Biopharma | June 23, 2026

AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy

Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients


India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
interviews | June 22, 2026

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors


Dr. Dhananjay Kumar Tiwary gets additional charge as Managing Director of BIRAC
People | June 22, 2026

Dr. Dhananjay Kumar Tiwary gets additional charge as Managing Director of BIRAC

Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies


FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens
Drug Approval | June 21, 2026

FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens

The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections


AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment
Medical Device | June 19, 2026

AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment

Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)


Siegfried opens major API manufacturing facility in Germany
News | June 18, 2026

Siegfried opens major API manufacturing facility in Germany

The expansion adds 100 m³ of reactor capacity, significantly strengthening Siegfried’s position among the world’s leading CDMOs for small-molecule drug substances


Suven reports positive Phase 2b results for Ropanicant in major depressive disorder
Clinical Trials | June 18, 2026

Suven reports positive Phase 2b results for Ropanicant in major depressive disorder

Suven has already begun planning a global Phase 3 registrational program for MDD based on the results


Indian Pharmacopoeia Commission delegation attends WHO-led international meet in Brazil
Policy | June 18, 2026

Indian Pharmacopoeia Commission delegation attends WHO-led international meet in Brazil

Highlights India’s advances in pharmacopoeial science, regulatory standards, and global harmonization efforts at the 16th International Meeting of World Pharmacopoeias


Vygon secures Health Canada approval for next-generation Stiletto Extended-Dwell Catheter
Medical Device | June 17, 2026

Vygon secures Health Canada approval for next-generation Stiletto Extended-Dwell Catheter

Approval paves the way for expansion in North America’s growing vascular access market, with innovative SlipStream technology designed to simplify catheter insertion and enhance patient care


Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial
Clinical Trials | June 16, 2026

Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial

The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor